Leslie Kean

Founding Scientist & Chief Scientific Officer Regatta Bio

Seminars

Wednesday 24th March 2027
Reviewing Clinical Development Strategies for Treg Therapies Across Global Studies
2:00 pm
  • Examining the rationale for advancing complementary Treg clinical programs across multiple geographies and indications
  • Evaluating early clinical observations from sorted Treg therapies in graft-versus-host disease and other immune-mediated settings
  • Determining how emerging clinical data can guide future development priorities and broader application of Treg therapies
Leslie